Related Experiment Video
Updated: Aug 5, 2026
13:58
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
ViraLite: an ultracompact HIV viral load self-testing system with internal quality control
Aneesh Kshirsagar1, Anthony J Politza2, Tianyi Liu3
1Department of Intelligent Systems Engineering, Luddy School of Informatics, Computing, and Engineering, Indiana University, Bloomington, IN, 47408, USA.
Microsystems & Nanoengineering
|July 28, 2026
Summary
A new ViraLite system offers decentralized HIV viral load (VL) testing using low sample volumes. This patient-operated device provides accurate results, improving HIV management outside clinics.
Area of Science:
- Biotechnology
- Medical Diagnostics
- Public Health
Background:
- Effective antiretroviral therapy (ART) manages HIV if viral load (VL) is suppressed.
- Limited access to frequent VL testing hinders effective HIV management, especially outside clinical settings.
- Decentralized, patient-operated VL testing requires reliable, low-volume systems with internal process controls.
Purpose of the Study:
- To develop and evaluate ViraLite, a compact, battery-powered system for decentralized HIV VL monitoring.
- To integrate key technologies for accurate, interpretable results in patient-operated settings.
- To address the challenge of ambiguous negative results in current VL testing methods.
Main Methods:
- ViraLite system utilizes reverse transcription loop-mediated isothermal amplification (RT-LAMP) and an RNase P internal process control.
- Machine learning-assisted fluorescence analysis enables one-pot multiplexing.
- Smartphone-guided operation and evaluation using 45 archived plasma samples against RT-qPCR.
Main Results:
- The internal process control correctly identified 17 inconclusive tests, preventing misclassification as negative.
- ViraLite demonstrated 93.3% sensitivity and 100% specificity compared to RT-qPCR for valid tests.
- The system requires minimal sample volume and provides interpretable negative results.
Conclusions:
- ViraLite facilitates decentralized HIV VL testing, enhancing patient-operated monitoring.
- This technology can overcome key barriers to VL testing access, expanding monitoring beyond traditional clinical workflows.
- ViraLite supports improved chronic HIV management through accessible and reliable viral load monitoring.
